ARROWHEAD PHARMACEUTICALS IN's ticker is ARWR and the CUSIP is 04280A100. A total of 316 filers reported holding ARROWHEAD PHARMACEUTICALS IN in Q2 2021. The put-call ratio across all filers is 0.51 and the average weighting 0.3%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $611,078 | -10.4% | 22,742 | +19.0% | 0.00% | 0.0% |
| Q2 2023 | $681,748 | +51.3% | 19,118 | +7.8% | 0.00% | +50.0% |
| Q1 2023 | $450,571 | -24.9% | 17,739 | +19.9% | 0.00% | -33.3% |
| Q4 2022 | $600,329 | +37.4% | 14,801 | +12.0% | 0.00% | 0.0% |
| Q3 2022 | $437,000 | -6.0% | 13,219 | 0.0% | 0.00% | 0.0% |
| Q2 2022 | $465,000 | -23.8% | 13,219 | -0.3% | 0.00% | 0.0% |
| Q1 2022 | $610,000 | -37.4% | 13,258 | -9.7% | 0.00% | -40.0% |
| Q4 2021 | $974,000 | +42.6% | 14,690 | +34.2% | 0.01% | +25.0% |
| Q3 2021 | $683,000 | -24.8% | 10,947 | -0.1% | 0.00% | -20.0% |
| Q2 2021 | $908,000 | +18.2% | 10,958 | -5.4% | 0.01% | 0.0% |
| Q1 2021 | $768,000 | -16.0% | 11,582 | -2.8% | 0.01% | -16.7% |
| Q4 2020 | $914,000 | +92.4% | 11,911 | +8.0% | 0.01% | +100.0% |
| Q3 2020 | $475,000 | -0.4% | 11,033 | 0.0% | 0.00% | -25.0% |
| Q2 2020 | $477,000 | +102.1% | 11,033 | +34.3% | 0.00% | +100.0% |
| Q1 2020 | $236,000 | -34.8% | 8,218 | +44.2% | 0.00% | -33.3% |
| Q4 2019 | $362,000 | +124.8% | 5,701 | 0.0% | 0.00% | +200.0% |
| Q3 2019 | $161,000 | +17.5% | 5,701 | +10.3% | 0.00% | 0.0% |
| Q2 2019 | $137,000 | +44.2% | 5,170 | 0.0% | 0.00% | 0.0% |
| Q1 2019 | $95,000 | +3.3% | 5,170 | -30.0% | 0.00% | 0.0% |
| Q4 2018 | $92,000 | -35.2% | 7,385 | 0.0% | 0.00% | 0.0% |
| Q3 2018 | $142,000 | +42.0% | 7,385 | 0.0% | 0.00% | 0.0% |
| Q2 2018 | $100,000 | +4900.0% | 7,385 | +450.3% | 0.00% | – |
| Q1 2017 | $2,000 | 0.0% | 1,342 | 0.0% | 0.00% | – |
| Q4 2016 | $2,000 | -80.0% | 1,342 | 0.0% | 0.00% | – |
| Q3 2016 | $10,000 | +42.9% | 1,342 | 0.0% | 0.00% | – |
| Q2 2016 | $7,000 | – | 1,342 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| WESTERN FINANCIAL Corp | 820,346 | $62,945,000 | 41.38% |
| Johnson & Johnson Innovation - JJDC, Inc. | 3,260,869 | $250,206,000 | 32.27% |
| Aquilo Capital Management, LLC | 365,926 | $28,078,000 | 5.84% |
| L1 Capital Pty Ltd | 298,687 | $23,127,000 | 4.32% |
| First Light Asset Management, LLC | 704,449 | $54,052,000 | 4.00% |
| ACUTA CAPITAL PARTNERS, LLC | 139,000 | $10,665,000 | 2.90% |
| Evolutionary Tree Capital Management, LLC | 48,265 | $3,703,000 | 2.82% |
| Parkman Healthcare Partners LLC | 127,171 | $9,758,000 | 2.50% |
| Capital Impact Advisors, LLC | 88,183 | $6,766,000 | 1.66% |
| Tri Locum Partners LP | 56,003 | $4,297,000 | 1.56% |